[Drug therapy in degenerative joint diseases].
D000818:Animals; D002358:Cartilage, Articular / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008012:Lidocaine / Q000627:therapeutic use; D010003:Osteoarthritis / Q000188:drug therapy*; D011720:Pyrazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D012459:Salicylates / Q000008:administration & dosage / Q000627:therapeutic use*; D013460:Sulfur Isotopes / Q000378:metabolism
D011720:Pyrazoles; D012459:Salicylates; D013460:Sulfur Isotopes; D008012:Lidocaine; D006854:Hydrocortisone; D007213:Indomethacin
Leki stosowane w chorobie zwyrodnieniowej stawòw.